Alder Biopharmaceuticals Inc (ALDR) ALD403 Meets Trial Targets

Alder Biopharmaceuticals Inc (NASDAQ:ALDR) recently took the opportunity at the American Headache Society meeting in San Diego to present data from clinical trials of its compound...

Keep Reading →